Mediators of inflammation in children with type I diabetes mellitus: Cytokines in type I diabetic children

Clinical Biochemistry

Volumn 34, Issue 8, 2001, Pages 645-650

  Erbaǧci, Ayşe Binnur ^a   Tarakçioǧlu, Mehmet ^a   Coşkun, Yavuz ^a   Sivasli, Ercan ^a   Sibel Namiduru, Emine ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Children; Interleukin 6; Interleukin 8; Tumor necrosis factor alpha; Type I diabetes mellitus

Indexed keywords

APOLIPOPROTEIN; C REACTIVE PROTEIN; GLUCOSE; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LIPID METABOLISM; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035714595     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(01)00275-2     Document Type: Article

References (32)

1. Immunogenetics of insulin-dependent diabetes mellitus
2. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus
3. Cytokines
4. TNF-α, and insulin resistance: Summary, and future prospects
5. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): A cohort study
6. Beta-cell ontogeny: Growth and death
7. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: Genetic and clinical implications
8. Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications
9. Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy
10. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes
11. Soluble tumor necrosis factor receptors in sera from patients with insulin-dependent diabetes mellitus: Relation to duration and complication of disease
12. Cytokine secretion is impaired in women with diabetes mellitus
13. Cytokine secretion patterns in twins discordant for type I diabetes
14. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: Comparison to long-standing diabetes and healthy individuals
15. Interleukin-1-beta, tumor necrosis factor-alpha, insulin secretion and oral glucose tolerance in non-diabetic siblings of children with IDDM
16. Significance of chemokines and activated platelets in patients with diabetes
17. Interleukin-8 production in human adipose tissue. Inhibitory effect of anti-diabetic compounds, the thiazollidinedione ciglitazone, and the biguanide metformin
18. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes
19. Diabetes-induced impairment of macrophage cytokine release in a rat model: Potential role of serum lipids
20. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats
21. A novel cellular receptor for advanced glycation end products
22. Carbohydrates
23. Decreased in vitro IL-4 (corrected) and IL-10 production by peripheral blood in first degree relatives at high risk of diabetes type-I
24. Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-gamma, interleukin-6, and interleukin-10, and under anti-CD95 induced apoptosis after insulin stimulation
25. Decreased secretion Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus
26. Dysregulation of in vitro cytokine production by monocytes during sepsis
27. Dissociation between plasma and monocyte-associated cytokines during sepsis
28. Serum levels of tumor necrosis factor-alpha are increased in obese patients with non-insulin-dependent diabetes mellitus
29. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
30. IL-6, and APPs: Anti-inflammatory, and immunosuppressive mediators
31. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses
32. Inflammatory markers in men with angiographically documented coronary heart disease